• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性透析患者甲状旁腺增生的超声介入:一种理论方法。

Ultrasonographic intervention of parathyroid hyperplasia in chronic dialysis patients: a theoretical approach.

作者信息

Fukagawa M, Kitaoka M, Kurokawa K

机构信息

First Department of Internal Medicine, University of Tokyo School of Medicine, Japan.

出版信息

Nephrol Dial Transplant. 1996;11 Suppl 3:125-9. doi: 10.1093/ndt/11.supp3.125.

DOI:10.1093/ndt/11.supp3.125
PMID:8840327
Abstract

Calcitriol pulse therapy has markedly changed the management of secondary hyperparathyroidism in chronic dialysis patients. However, there are still many patients even resistant to this therapy. Our observation of parathyroid size by ultrasonography revealed that these patients usually have enlarged parathyroid glands larger than 0.5 cm3. Such large parathyroid glands are composed of nodular hyperplasia with monoclonal cell proliferation, whose calcitriol receptor density is lower than that of diffuse hyperplasia, thus more resistant to calcitriol. Based on such a pathophysiological model, we have shown that destruction of the largest parathyroid gland was sufficient to restore the responsiveness to calcitriol therapy in these refractory patients. By using colour Doppler ultrasonography, we could also optimize the site and volume of ethanol injection and could detect the recurrence of parathyroid cell growth easily, with lower risk of complications. This selective route of drug delivery to parathyroid glands can be also used for direct injections of calcitriol solution as we have reported. Thus, evaluation of parathyroid size by sensitive ultrasonography is an essential marker for the management of parathyroid hyperfunction in chronic dialysis patients. It is also suggested that ultrasonographic intervention of parathyroid hyperplasia may not only be a useful and safe adjunct to calcitriol pulse therapy, but may also serve as a new therapeutic modality for parathyroid diseases in future.

摘要

骨化三醇冲击疗法显著改变了慢性透析患者继发性甲状旁腺功能亢进的治疗方式。然而,仍有许多患者对此疗法耐药。我们通过超声对甲状旁腺大小进行观察发现,这些患者的甲状旁腺通常肿大,体积超过0.5立方厘米。如此大的甲状旁腺由结节性增生组成,伴有单克隆细胞增殖,其骨化三醇受体密度低于弥漫性增生,因此对骨化三醇更具耐药性。基于这样的病理生理模型,我们已表明,破坏最大的甲状旁腺足以恢复这些难治性患者对骨化三醇治疗的反应性。通过使用彩色多普勒超声,我们还可以优化乙醇注射的部位和体积,并能轻松检测甲状旁腺细胞生长的复发情况,并发症风险较低。正如我们所报道的,这种向甲状旁腺给药的选择性途径也可用于直接注射骨化三醇溶液。因此,通过敏感的超声评估甲状旁腺大小是慢性透析患者甲状旁腺功能亢进治疗的重要指标。还表明,甲状旁腺增生的超声干预不仅可能是骨化三醇冲击疗法有用且安全的辅助手段,而且未来可能成为甲状旁腺疾病的一种新治疗方式。

相似文献

1
Ultrasonographic intervention of parathyroid hyperplasia in chronic dialysis patients: a theoretical approach.慢性透析患者甲状旁腺增生的超声介入:一种理论方法。
Nephrol Dial Transplant. 1996;11 Suppl 3:125-9. doi: 10.1093/ndt/11.supp3.125.
2
Pathogenesis and medical treatment of secondary hyperparathyroidism.继发性甲状旁腺功能亢进的发病机制与医学治疗
Semin Surg Oncol. 1997 Mar-Apr;13(2):73-7. doi: 10.1002/(sici)1098-2388(199703/04)13:2<73::aid-ssu2>3.0.co;2-z.
3
Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients.通过乙醇注射减少慢性透析患者中具有功能的甲状旁腺细胞数量。
Kidney Int. 1994 Oct;46(4):1110-7. doi: 10.1038/ki.1994.373.
4
Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients.通过超声对甲状旁腺大小进行系列评估是慢性透析患者骨化三醇脉冲治疗长期预后的另一个有用指标。
Nephron. 1994;68(2):221-8. doi: 10.1159/000188261.
5
Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patients.慢性透析患者甲状旁腺增大的经皮马沙骨化醇注射治疗的手术验证
Nephrol Dial Transplant. 2003 Jun;18 Suppl 3:iii50-2. doi: 10.1093/ndt/gfg1013.
6
Relationship between the dimension of parathyroid glands estimated by ultrasonography and the hyperplastic pattern in patients with renal hyperparathyroidism.超声检查估计的甲状旁腺大小与肾性甲状旁腺功能亢进患者增生模式的关系。
Ther Apher Dial. 2008 Oct;12(5):391-5. doi: 10.1111/j.1744-9987.2008.00615.x.
7
Clinical features and hyperplastic patterns of parathyroid glands in hemodialysis patients with advanced secondary hyperparathyroidism refractory to maxacalcitol treatment and required parathyroidectomy.接受帕立骨化醇治疗无效且需要进行甲状旁腺切除术的晚期继发性甲状旁腺功能亢进血液透析患者甲状旁腺的临床特征及增生模式
Ther Apher Dial. 2007 Aug;11(4):266-73. doi: 10.1111/j.1744-9987.2007.00489.x.
8
Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients.血液透析患者的骨化三醇脉冲疗法与甲状旁腺组织学
J Nephrol. 2003 Sep-Oct;16(5):716-20.
9
[Ultrasonography methods in the diagnosis of renal osteodystrophy].[超声检查法在肾性骨营养不良诊断中的应用]
Acta Med Croatica. 2004;58(1):43-9.
10
Intravenous calcitriol therapy in an early stage prevents parathyroid gland growth.早期静脉注射骨化三醇疗法可预防甲状旁腺生长。
Nephrol Dial Transplant. 2008 Nov;23(11):3662-9. doi: 10.1093/ndt/gfn264. Epub 2008 May 30.

引用本文的文献

1
Association between long-term efficacy of cinacalcet and parathyroid gland volume in haemodialysis patients with secondary hyperparathyroidism.西那卡塞对继发性甲状旁腺功能亢进血液透析患者的长期疗效与甲状旁腺体积之间的关联。
NDT Plus. 2008 Aug;1(Suppl 3):iii49-iii53. doi: 10.1093/ndtplus/sfn087.